首页> 美国卫生研究院文献>Journal of Cellular and Molecular Medicine >The role of macrophages polarization in predicting prognosis of radically resected gastric cancer patients
【2h】

The role of macrophages polarization in predicting prognosis of radically resected gastric cancer patients

机译:巨噬细胞极化在预测胃癌根治术后患者预后中的作用

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Tumour-associated Macrophages (TAM) present two different polarizations: classical (M1) characterized by immunostimulation activity and tumour suppression; alternative (M2) characterized by tumour promotion and immune suppression. In this retrospective study, we evaluated the correlation between the two forms of TAM with survival time in radically resected gastric cancer patients. A total of 52 chemo- and radio-naive patients were included. Two slides were prepared for each patient and double-stained for CD68/NOS2 (M1) or CD68/CD163 (M2) and five representative high-power fields per slide were evaluated for TAM count. The median value of the two macrophage populations density and the median value of M1/M2 ratio were used as cut-off. Twenty-seven patients with M1 density above-the-median had a significantly higher survival compared to those below the median. Twenty-six patients with M1/M2 ratio above the median showed median OS of 27.2 months compared to 15.5 months of the patients below the median. No association between M2 macrophage density and patient's outcome was found. In multivariate analysis, M1/M2 was a positive independent predictor of survival. The M1 macrophage density and M1/M2 ratio, as confirmed in multivariate analysis, are factors that can help in predicting patients survival time after radical surgery for gastric cancer.
机译:肿瘤相关的巨噬细胞(TAM)表现出两种不同的极化:以免疫刺激活性和肿瘤抑制为特征的经典(M1);替代品(M2),其特征在于促进肿瘤和抑制免疫。在这项回顾性研究中,我们评估了两种形式的TAM与根治性胃癌患者生存时间的相关性。总共包括52名未接受化学和放射治疗的患者。为每位患者准备了两张玻片,并对CD68 / NOS2(M1)或CD68 / CD163(M2)进行了双染色,并对每张玻片的五个代表性高倍视野进行了TAM计数评估。以两个巨噬细胞种群密度的中位数和M1 / M2比的中位数作为临界值。 M1密度高于中位数的27例患者的生存率明显低于中位数。 M1 / M2比率高于中位数的26名患者显示中位OS为27.2个月,而低于中位数的患者为15.5个月。未发现M2巨噬细胞密度与患者预后之间存在关联。在多变量分析中,M1 / M2是生存的阳性独立预测因子。多变量分析证实,M1巨噬细胞密度和M1 / M2比值可以帮助预测胃癌根治术后患者的生存时间。

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号